Andy Sassine - 12 Jun 2024 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Chief Financial Officer, Director
Signature: /s/ Ilan Katz, attorney-in-fact
Issuer symbol: ARCT
Transactions as of: 12 Jun 2024
Transactions value $: -$1,601,500
Form type: 4
Date filed: 14 Jun 2024, 16:06
Previous filing: 03 Apr 2024
Next filing: 19 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARCT	Common Stock	Sale	-$1.6M	-50K	-18.48%	$32.03	221K	12 Jun 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected in open market transactions by the Reporting Person.
F2	Reflects the weighted average price of 50,000 shares of common stock of Arcturus Therapeutics Holdings Inc. (the "Issuer") sold by the Reporting Person in multiple transactions on June 12, 2024, with sales prices ranging from $31.52 to $33.54 per share. The Reporting Person undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Content

The sales reported on this Form 4 were effected in open market transactions by the Reporting Person.

Reflects the weighted average price of 50,000 shares of common stock of Arcturus Therapeutics Holdings Inc. (the "Issuer") sold by the Reporting Person in multiple transactions on June 12, 2024, with sales prices ranging from $31.52 to $33.54 per share. The Reporting Person undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.